Quantitative determination of carvedilol in human plasma by highperformance liquid chromatography using fluorescence detection

Carvedilol is a pharmaceutical substance listed in the “Regulatory requirements of bioequivalence study reports for generic drugs containing APIs upon applying for marketing authorization”. Therefore, a simple method for quantifying carvedilol in human plasma is desirable.